Although CH-associated mutations have primarily been studied in myeloid malignancies, recent studies have reported ASXL1 mutations in T-cell–mediated conditions such as aplastic anemia (AA) [14] and large granular lymphocytic leukemia (LGLL) [15]. This evidence concerns the gene ASXL1 and myeloid neoplasm.